receptors.
At 4"C, [3H]GABA binding to GABA, receptors reached equilibrium within 45 min. The association and dissociation rate constants for GABA, binding to outer neocortical layers were 2.87 5 0.17 x lo5 min-' M-' and 0.0966 f 0.0118 min-', respectively, indicating a dissociation constant of 336 + 40 nM. Saturation binding studies in the same region yielded a dissociation constant for GABA, receptors of 341 f 41 nM while that of GABA, receptors was 92 & 10 nM. While the affinities of each type of GABA receptor were uniform across brain regions, the maximal number of binding sites for both types of GABA receptor varied across regions. The distributions of the two receptors in rat brain were different in the olfactory bulb, cerebellum, thalamus, neocortex, medial habenula and interpeduncular nucleus. Areas high in GABA, binding included the medial and lateral geniculates, the superior colliculus and certain amygdaloid nuclei. Binding to white matter tracts and ventricles was negligible. The distribution of GABA, receptors was in agreement with previously postulated sites of action of baclofen.
Much evidence supports the existence of at least two classes of receptors for the inhibitory amino acid neurotransmitter GABA.",25.27 These pharmacologically and physiologically distinct classes of GABA receptors have been termed the GABA, and GABA, receptors. Several agonists selectively activate GABA, receptors, including muscimol,67 isoguvacine42 and 4, 5, 6, .'* To date, baclofen (Lioresal, p-chlorophenyl GABA) is the only known agonist selective for GABA, receptors. '2~14 GABA, receptors have traditionally been characterized by their sensitivity to blockade by the GABA antagonist, bicucu11ine,46 while GABA, receptors are by definition bicucullineinsensitive."
Both types of GABA receptors cause inhibition, but activate different ionic mechanisms.26 GABA, receptors are coupled to the benzodiazepine/barbiturate receptor-linked chloride channel.35.55.79 GABA, receptors have been associated with an inhibitory GTP-binding protein2 and adenylate cyclase activity. 3.4'.83 In hippocampal pyramidal neurons, GABA, receptor activation is associated with an increased outward potassium conductance2,32.43 or a calcium-dependent potassium conductance.' The effect of baclofen on dorsal root ganglion neurons, however, is a direct decrease in calcium conductance. 23.26 GABA receptor autoradiography also indicates that these two receptors have distinct anatomical *To whom correspondence should bc addressed. Abbreviation: THIP, 4, 5, 6, The concentrations of baclofen and isoguvacine needed to block binding to either GABA, or GAB& receptors, respectively, were determined in seoarate inhibition exneriments.
Non-soecific I'HlGABA binding was determined-by the inclusion bf lOO;i isoguvacine and 100 PM (+)baclofen.
Unless otherwise indicated, assay conditions for both GABA, and GABA, binding sites involved a 45 min incubation at 4'C with ['HIGABA in 50 mM Tris-HCl + 2.5 mM CaC& (pH 7.40). Slides were placed in vials containing the radioligand-buffer mixture. After incubation slides were individually removed, subjected to three rapid squirts with buffer followed by one quick rinse with 2.5% glutaraldehyde in acetone and immediately blown dry with warm air. This rinse-and-dry procedure was completed within 15 s. The slides were mounted in an X-ray cassette and apposed to a sheet of tritium-sensitive Ultrofilm-'H (LKB) for 3 weeks at 4°C. After that time, the films were developed in Kodak Dl9 for 3 min at 25"C, fixed and dried. The films were placed in a photographic enlarger and optical densities in various regions of the film were quantified using computer-assisted microdensitometry with a spot densitometer. between the amount of radioactivity and the optical density was described by a computer-generated fourth order polynomial function.
Determination cf kinetic constants
Separate experiments to study the association and dissociation of ['H]GABA to GABA, receptors were conducted using fou; animals for each study. 
Inhibition experiments

Competition
of ['HIGABA binding by isoguvacine or baclofen was investigated in separate series of experiments (each n = 4). Isoguvacine competition assays were conducted in the absence of any baclofen; however, baclofen competition experiments were performed in the presence of 40 PM isoguvacine. Hill plots were constructed to determine lcsO values for binding to discrete layers of the cerebellum.
K, values were calculated according to the equation:
Regional distribution of GABA receptor subtypes
Total GABA, GABA, and GABA, binding sites were mapped in serial sections at nine coronal levels of the rat brain using [3H]GABA (23 nM, 71.5 Ci/mmol). Values of [IH] GABA bound under GABA,-or GABA,-preferring conditions were quantified in several regions of interest in four animals. As before, non-specific binding was that which remained on adjacent sections in the presence of 1OOpM isoguvacine and 100 PM (&)baclofen. The corresponding tissue sections were stained for Nissl substance with Cresyl Violet to identify the structures in the autoradiograms.
RESULTS
Kinetics of' [3H]GABA binding to bacloj&-sensitive
GABA, sites in rat brain
Binding of ['H]GABA to GABA, sites reached equilibrium within 45 min at 4°C (Fig. 1) . Preliminary studies revealed that GABA, binding at 4°C for 45 min was identical in all respects to GABA, binding at 20°C for 20min, with the advantage that nonspecific binding was greatly reduced at the lower temperature. Binding to baclofen-sensitive GABA, sites was reversible and displayed association and dissociation rate constants within layer I-III of cerebral cortex of 2.87 _t 0.17 x 10s/min per M and 0.097 Ifr O.O12/min, respectively. These values yielded an equilibrium dissociation constant (K,,) of 336 f 40 nM. This estimate of GABA, affinity was in close agreement with the value of 341 f 41 nM for cerebral cortex as disclosed by saturation experiments (Table 1) . Figure 2 shows a typical saturation isotherm and the associated Scatchard plot for layers I-III of cerebral cortex. The binding affinity (Kn) of [3H]GABA for GABA, receptors was roughly three-to four-fold less than its affinity for GABA, receptors (Table 1) . The Kr, values of GABA, binding sites in various regions of the rat CNS generally ranged from 300 to 500 nM, whereas the Kn values of GABA, binding sites were within the range of lOCk200 nM. While the affinities of GABA, and GABA, receptors were fairly constant across different brain regions, their densities (B,,,,,) varied from region to region. For example, within cortical layers I-III there were roughly equal numbers of GABA, and GABAA receptors, while more GABA, than GABA, receptors were present in layer IV. Similarly, the molecular layer of the cerebellum was enriched in GABA, receptors while GABAA receptors were more numerous in the cerebellar granule cell layer. In striatum and dentate gyrus, where both types of receptors were found, GABA, binding sites accounted for roughly 40% of all GABA receptors. The Hill coefficients for both GABA, and GABA, binding sites in several regions were close to unity (Table I) . Displacement studies in the cerebellum (Fig. 3 ) demonstrated that a combination of 40 y M isoguvacine plus 100 p M ( + )baclofen was able to displace all specific ['HIGABA binding. These data suggest that under these conditions only single populations of GAlBAA and GABAs receptors can be distinguished.
ASSOCIATION AND DISSOCIATION CURVES FOR GABAB RECEPTOR BINDING IN CEREBRAL CORTICAL LAYERS I-III
SATURATION CURVE AND SCATCHARD PLOT OF GABAs BINDING IN RAT CEREBRAL CORTICAL LAYERS I-III
Regional di~trjbut~on qf" GABA, and GABA, binding sites in rat brain
Specific t3H]GABA binding of GABA, and GABA, receptors in a number of brain regions is shown in Table 2 . The distribution of GABA, and GABA, binding sites displayed marked heterogeneity in some regions, and striking similarity in others, as demonstrated in the autoradiograms and corresponding Nissl-stained sections in Fig. 49 . For example, in the olfactory bulb, GABA, binding was highest in the glomerular layers, whereas GABA, binding occurred predominantly in the external plexiform and inner granular layers. In several other regions, as exemplified by the geniculate bodies and superior colliculus, the distribution of GABA, receptors paralleled that of GABA* receptors.
[RHIGABA exhibited differential binding to GABA, and GABA, sites in various cortical layers and lobes. Binding to both types of GABA receptors was highest in parietal cortex, followed in order by striate, temporal, frontal, retrosplenial, piriform and entorhinat cortices. The anterior cingulate cortex exhibited greater [3H]GABA binding than did the posterior cingulate cortex. In general, binding to GABA, receptors occurred in a distinct laminar pattern to cortical layers I-IV and Via, while GABA, binding was primarily restricted to cortical layers I-III.
With notable exceptions, a consistent finding in virtually all brain regions examined was that GABA, binding accounted for roughly 70-80% of total ['HIGABA binding, while GABAs binding represented 2C&30% (Table 2 ). Exceptions to this generalization were seen in the medial habenula, the glomerular layer of the olfactory buib, the superficial gray of the superior colliculus, the interpeduncular nucleus, the pontine nuclei, and the molecular layer of the cerebellum. These regions exhibited the highest levels of GABA, binding, where these receptors accounted for as much as 90% of total 13H]GABA binding. Other regions exhibiting high absolute values of GABA, binding sites were found in various cortical and thalamic structures and certain amygdaloid subnuclei (see Table 2 ).
Brain regions which exhibited intermediate levels of GABA, binding included the external plexiform layer of the olfactory bulb, accessory olfactory nucleus, lateral septal nuclei, posterior cingulate cortex, ventrolateral and ventromedial thalamus, anterior cortical and medial amygdala, the molecular layer of the dentate gyrus, and the granular layer of the cerebellum. Relatively low amounts of binding to GABAB receptors (< 0.1 pmol/mg protein) were observed in the neostriatum, globus pallidus, hippocampal formation, substantia nigra and other brainstem regions. GABA, binding to white matter tracts or ventricles was indistinguishable from non-specific background levels.
GABA, receptors generally predominated in cortical, septal and hippocampal regions as well as in certain thalamic relay nuclei (VPM and the genicuiate bodies). Binding to GABA, receptors was also high in the external plexiform layer of the olfactory bulb and the granular layer of the cerebellum. Intermediate levels of binding to GABA, receptors occurred in basal ganglia, basal forebrain, amygdala, thalamus, superficial gray of the superior colliculus, central nucleus of the inferior colliculus, pre-and parasubiculum and the molecular layer of the cerebellum. Low amounts of GABA, binding were found in the hypothalamus, habenula, mammillary bodies, subthalamus, substantia nigra, and other midbrain and pontine regions.
DISCUSSION
Kinetics of ['H]GABA binding
The distribution of GABA, receptors as revealed by [3H]GABA autoradiography confirms and extends the findings of previous autoradiographic and homogenate binding studies which have used either [3H]( -)baclofen or [3H]GABA as ligands for GABA, receptors. '2~'3~15~24~34~42~8i The technique described here provides a sensitive assay for dete~ining the affinity and number of both GABA, and GABA, receptors in anatomically discrete brain regions.
One concern is whether a component of the observed [3H]GABA binding sites could represent uptake or sequestration of the ligand into membrane-bound saccules. However, the specific [3H]GABA binding assay used here is unlikely to reflect binding to the GABA uptake site for the following reasons. Sodium ions, which have been shown to be required for [3H]GABA uptake binding in tissue homogenates,"' have been excluded from the assay medium. Furthermore, a specific antagonist of the GABA uptake site, nipecotic acid, did not block any component of [3H]GABA binding (unpublished observations). The autoradiographic method involves freezing and thawing of brain sections-a step which has been shown to disrupt membrane-bound saccules.47 The equilibrium dissociation constant (Ko) derived by kinetic experiments agreed well with the K,, determined by equilibrium saturation experiments-a feature of reversible equilibrium binding conditions that is inconsistent with sequestration of label into membrane saccules. In addition, all steps in the present assay were performed in hypotonic (50mM) Tris buffer, which reduces uptake by lysis of membrane-bound saccules4' The binding constants obtained in this study were consistent with those reported previously for GABAs sites in homogenate studies using [3H]GABA54 and [3H]baclofen. I3 In the presence of 2.5 mM CaCl, and 10 PM isoguvacine, Scatchard plots of GABA, binding were linear and yielded Hill coefficients close to unity. Likewise, [3H]GABA appeared to bind to a single GABA, site in the presence of 100 PM (f)baclofen.
Thus, ['H]GABA appeared to bind to homogeneous GABA, and GABA, receptor populations. However, other populations of GABA, and GABA, sites demonstrating much lower affinity or more rapid dissociation kinetics may have gone undetected by our assay conditions.
Using similar ionic conditions, others have shown monophasic GABA, binding in tissue homogenates.'* Some studies, however, have resolved two baclofensensitive ['H]GABA sites." [3H]( -)Baclofen itself had been shown to bind to a single site in rat forebrain sections34 and in rat cerebellar membranes.24,50 Bowery et a1.l3 have found that [3H]( -)baclofen binds to two sites in rat brain membranes with high and low affinities of 19 and 304 nM, respectively. They also describe two baclofen-sensitive t3H]GABA binding sites with affinities of 29 and 1242 nM, in contrast to their previous findings of a single site. '* This discrepancy was attributed to the use of excess radioligand (> 10 nM) in the earlier study which would have revealed only the low affinity site. A higher affinity GABA, site in our assay may also have gone undetected, but such a high affinity site was investigated by using ['H]GABA concentrations from 5 to 20 nM for the lower points in the saturation curve.
Although the GABA, binding site exhibited a KD of approximately 300 nM, it displayed rather slow association and dissociation kinetics. These two features are not incompatible, as the K,, derived from the kinetic experiments agreed very well with K, values obtained from saturation studies. The relatively slow on and off rates for [3H]GABA may reflect the low temperature (4°C) at which the assay was conducted. It is unlikely that these values reflect artifactual kinetics, as a discrepancy between KD values obtained from kinetic and saturation studies would be expected in that case.
Distribution of [3H]GABA binding
The present study extends previous autoradiographic descriptions of the localization of GABA, and GABA, receptors 15s6~8' by providing direct quantitative comparison of the affinity and number of GABA, versus GABA, receptors in discrete brain regions (Tables 1 and 2 , Figs 4-9), and by obtaining kinetic constants within the same animals using quantitative autoradiography (Fig. 1) . We also report detailed displacement curves for baclofen and isoguvacine from data obtained in serial autoradiographic sections (Fig. 3) .
Our findings are in close agreement with an earlier study by Bowery et al. " However, differences in methodology between the present and the earlier study should be pointed out. Bowery et a1.'5 performed assays in brains fixed by paraformaldehyde perfusion. They used IO-pm-thick sections, room temperature incubations in hypotonic buffer, brain paste standards for calibration of optical densities, and reported bound values in pmol/g wet weight tissue. Furthermore, KD and B,,,, values were reported for GABA, and GABA, binding to whole brain sections and not from distinct areas of the brain. Despite these differences in methods, however, the regional localization of GABA, and GABA, binding sites demonstrated by our assay is in excellent agreement with that of Bowery's earlier report.
The general trend apparent from regional distribution results is that the ratio of GABA, vs GABA, binding at a single concentration of [-'H] GABA is roughly 1: 3-l :4. This ratio may primarily reflect differences in receptor affinity, as GABA* receptors exhibit three-to four-fold higher affinities for [3H]GABA than GABA, receptors (Table 1) . Regions where differences in receptor number may outweigh those in receptor affinity typically exhibit other ratios. For instance, in the cerebellar granule cell layer, GABA, receptors are four times more numerous than GABA, receptors; but in the molecular layer, GABA, receptors outnumber GABA, receptors (Table 1) .
The greater affinity and apparently greater number of GABA, than GABA, receptors in several brain regions may account for certain electrophysiological observations. Activation of GABA, receptors by GABA may be easier to detect in vitro when GABAA receptors are masked by bicuculline.32 The differential affinity may also contribute to differences in the onset of GABA,-vs GABA,-mediated membrane events. GABA,-mediated membrane effects are usually slower in onset and longer in duration than GABA, membrane activation. 32*M) Since GABA, receptors have a higher KD than do GABA, receptors, GABA released into the synaptic cleft might first interact with GABA, receptors. As the amount of GABA released into the synaptic cleft accumulates over time, GABA, receptor activation could be recruited. The difference in time of onset of observable electrophysiological effects of GABA could also be related to the slow association time at GABAs receptors and the fact that GABA, receptors are coupled to inhibitory guanine-nucleotide binding proteins.2 Table 2 details the existence of GABA, sites previously undetected by biochemical, behavioral or physiological methods. The highest density of GABA, sites was found in the medial habenula. It is not clear if GABA, receptors in the medial habenula are innervated by local interneurons or by an extrinsic GABAergic source. Putative extrinsic GABAergic afferents to the medial habenula may come from the nucleus of the diagonal band of Broca.'* Efferent projections from the medial habenula innervate the interpeduncular nucleus." The interpeduncular nucleus has the second highest level of GABA, binding in the rat brain. Habenular stimulation has resulted in analgesia in animal models of chronic pain.-That GABA, receptors are highest in the medial habenula and interpeduncular nucleus may correlate with some of the analygesic effects of baclofen observed clinica11y"",7x and experimentally.7.20~36~s3 However, whether baclofen affects transmission along the habenulointerpeduncular tract remains to be investigated. Price et al.," suggested that interpeduncular GABA, receptors may exist on presynaptic terminals of fasciculus retroflexus afferents from the medial habenula.
In their study, kainateor ibotenateinduced lesions of intrinsic interpeduncular neurons did not cause reductions in GABA, receptor binding, while electrolytic habenular lesions result in 85% loss of interpeduncular GABA, sites 12 days post-lesion. Other brain regions possess GABA, receptors whose physiological function is unknown. These include the lateral and medial geniculate bodies, various thalamic nuclei and the superior colliculus. These regions, however, do exhibit glutamate decarboxylase-positive reaction product'" and dendrodendritic synapsesZ9," GABA, receptors in these areas could be involved in dendrodendritic inhibition. In general, GABA receptor distribution parallels the topography of glutamate decarboxylase-positive'" and GABA-immunoreactive terminals.6J An exception to this trend is observed in the globus pallidus, where little [3H]GABA binding occurs despite welldocumented presynaptic markers. This discrepancy could in part reflect quenching of tritium label by the rich network of white matter tracts which traverse this structure." from cortical slices. Cortical GABA, receptors are decreased after lesion of the dorsal adrenergic bundle.48 These data suggest that GABA, receptors may exist as presynaptic heteroreceptors on cortical afferents where they attenuate release of excitatory amino acids and biogenie amines. GABA, receptors are localized primarily in outer layers (I-III) of cerebral cortex. The outer layers of cortex receive afferents predominantly from cortico-cortical association fibers," which most likely use glutamate or aspartate as a neurotransmitter.'.40 The laminar distribution of serotonin" and noradrenergic" input to the neocortex is more uniform and not confined to the outer layers of cortex. Therefore, if cortical CABA, binding sites represent true heteroreceptors, they are likely to be largely on glutamatergic cortico-cortical afferents. However, the possibility that GABA, receptors may exist on postsynaptic intrinsic cortical neurons cannot be disregarded.
Striatal GABA, receptors are few in number when compared to the density of striatal GABA, receptors. Baclofen, acting at presumptive presynaptic GABA, receptors in the striatum, reduces the evoked release of dopamine'" and potentiates the release of [Met]-enkephalin from rat striatal slices.76 GABA, receptors may also exist on corticostriatal terminals, based on preliminary anatomical lesion data.51 In addition, baclofen reduces field potentials evoked by stimulation of cortical efferents.21 However, intracellular recordings from caudate neuronsa have shown that systemic or intracaudate baclofen does not reduce excitatory postsynaptic potentials in response to cortical or thalamic stimulation, but blocks evoked hyperpolarizations. This suggests that baclofen has no effect upon striatal afferents, but that it exerts a direct effect on intracaudate circuitry. Thus, baclofen-sensitive GABA, receptors may exist on postsynaptic neurons within the striatum. Lesion studies from our laboratory indicate that striatal GABA, receptors are unchanged after decortication but are markedly reduced after striatal ibotenate lesions.r9
The differential laminar localization of GABA, and GABA, receptors in the cerebellum confirms previous reports.15~8' We also find the molecular layer to be enriched in GABA, receptors, and the granular layer to have the greatest density of GABA, receptors in rat brain. Studies in mutant mice indicate that GABA, receptors in the molecular layer of the cerebellum may be localized on Purkinje cell dendritesI and on parallel fibers from granule cells." Kato and Fukuda" found that lesions of the inferior olive result in decrements of cerebellar GABA, receptors and proposed that GABA, receptors may exist on climbing fiber afferents to the cerebellum.
CONCLUSION
The regional distribution and kinetic properties of GABA, binding in rat brain are in excellent agreement with previous GABA, binding studies. The distribution of GABA, sites within rat brain correlates well with sites where baclofen has been shown to have biochemical and electrophysiological actions. In addition, GABA, sites are highest in the medial habenula and interpeduncular nucleus, where they may be involved in central pain pathways. 
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